Real Data.
Real Doctors.
Real Results.

THE SCIENCE

Behind semaglutide & tirzepatide.

GLP-1 medications mimic a hormone that regulates appetite, so you feel full sooner and stay full longer, and eating less feels natural instead of forced. Under a clinician's guidance, that becomes a steady, sustainable pace.

✓Appetite & craving control

✓More energy

✓Improved mood

✓Steady, sustainable pace

See the weight program →

SEMAGLUTIDE — BRANDED, FDA-APPROVED

~15%average body-weight loss

Mean reduction over 68 weeks (STEP 1 trial¹). Result from a clinical trial of a branded, FDA-approved medication — not a claim about LodeRx compounded product.

SEMAGLUTIDE — BRANDED, FDA-APPROVED

~69%lost 10% or more

Participants losing ≥10% of body weight (STEP 1¹). Result from a clinical trial of a branded, FDA-approved medication — not a claim about LodeRx compounded product.

TIRZEPATIDE — BRANDED, FDA-APPROVED

~21%average body-weight loss

Mean reduction over 72 weeks at 15 mg (SURMOUNT-1²). Result from a clinical trial of a branded, FDA-approved medication — not a claim about LodeRx compounded product.

TIRZEPATIDE — BRANDED, FDA-APPROVED

~57%lost 20% or more

Participants losing ≥20% at 15 mg (SURMOUNT-1²). Result from a clinical trial of a branded, FDA-approved medication — not a claim about LodeRx compounded product.

¹ Wilding JPH et al., STEP 1 (NEJM, 2021): semaglutide 2.4 mg, 68 weeks. ² Jastreboff AM et al., SURMOUNT-1 (NEJM, 2022): tirzepatide 15 mg, 72 weeks. The figures above are results reported in clinical trials of branded, FDA-approved medications used with diet and activity. They are not claims about LodeRx compounded products. Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not clinically proven to produce the results of FDA-approved GLP-1 medications. Individual results vary and are not guaranteed.